Icon Wealth Advisors LLC Boosts Stock Position in Danaher Co. (NYSE:DHR)

Icon Wealth Advisors LLC raised its stake in shares of Danaher Co. (NYSE:DHR) by 5.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,612 shares of the conglomerate’s stock after buying an additional 195 shares during the quarter. Icon Wealth Advisors LLC’s holdings in Danaher were worth $1,004,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in DHR. PGGM Investments bought a new position in Danaher in the 1st quarter valued at approximately $459,000. Cetera Investment Advisers lifted its holdings in shares of Danaher by 338.0% during the first quarter. Cetera Investment Advisers now owns 122,223 shares of the conglomerate’s stock valued at $30,522,000 after purchasing an additional 94,318 shares in the last quarter. Cetera Advisors LLC boosted its position in shares of Danaher by 44.3% during the first quarter. Cetera Advisors LLC now owns 27,346 shares of the conglomerate’s stock valued at $6,829,000 after buying an additional 8,389 shares during the last quarter. Cetera Advisor Networks LLC increased its holdings in Danaher by 6.3% in the 1st quarter. Cetera Advisor Networks LLC now owns 72,454 shares of the conglomerate’s stock worth $18,093,000 after buying an additional 4,266 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in Danaher by 5.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 1,366 shares of the conglomerate’s stock worth $337,000 after buying an additional 69 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on DHR. UBS Group reduced their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Barclays cut their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. KeyCorp lifted their price objective on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, Evercore ISI increased their target price on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Stock Up 0.4 %

NYSE DHR opened at $239.84 on Friday. The stock has a 50 day moving average price of $254.59 and a 200-day moving average price of $259.44. Danaher Co. has a one year low of $215.68 and a one year high of $281.70. The company has a market capitalization of $173.23 billion, a P/E ratio of 45.77, a P/E/G ratio of 4.39 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue was up 3.1% on a year-over-year basis. During the same period last year, the company posted $2.02 EPS. As a group, equities analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.